Transaction fees drive MedAdvisor growth

The introduction of new transaction fees is contributing to revenue growth for MedAdvisor Solutions  Transaction fees for vaccinations and “services associated with Project STOP” are already boosting medication management software provider, MedAdvisor’s revenue.  In an update to the Australian Securities Exchange (ASX), the company reported “strong revenue growth” for the quarter ending 31 March.